SC 13G: Silo Pharma, Inc.

AI Summary

SC 13G filing by Silo Pharma, Inc..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.0001 — ame of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• ea0207788-13gintra_silo.htm (SC 13G) — 61KB
• ea020778801ex99-1_silo.htm (EX-99.1) — 4KB
• 0001213900-24-052491.txt ( ) — 67KB

If this statement is filed pursuant

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: Not applicable. Page 5 of 8 Item 4. Ownership. (a) and (b): (i) Immediately following the execution of the Securities Purchase Agreement with the Issuer on Jun 4, 2024 (the “ SPA ”) (as disclosed in the Form 8-K filed by the Issuer with the Securities and Exchange Commission on June 6, 2024), each of the Reporting Persons may have been deemed to have beneficial ownership of 311,141 shares of Common Stock, which consisted of (i) 310,000 shares of Common Stock to be issued to Intracoastal at the closing of the transaction contemplated by the SPA and (ii) 1,141 shares of Common Stock issuable upon exercise of a warrant to be issued to Intracoastal at the closing of the transaction contemplated by the SPA (“ Intracoastal Warrant 1 ”), and all such shares of Common Stock in the aggregate represent beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 2,803,386 shares of Common Stock outstanding as of June 4, 2024 as reported by the Issuer, plus (2) 310,000 shares of Common Stock to be issued to Intracoastal at the closing of the transaction contemplated by the SPA and (3) 1,141 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1. The foregoing excludes (I) 32,896 shares of Common Stock issuable upon exercise of Intercoastal Warrant 1 because Intracoastal Warrant 1 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 1 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder’s affiliates, and any other persons acting as a group together with the holder or any of the holder’s affiliates, of more than 9.99% of the Common Stock and (II) 344,037 shares of Common Stock issuable upon exercise of a second warrant t

Certification

Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11. Page 7 of 8 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: June 13, 2024 /s/ Mitchell P. Kopin Mitchell P. Kopin /s/ Daniel B. Asher Daniel B. Asher Intracoastal Capital LLC By: /s/ Mitchell P. Kopin Mitchell P. Kopin, Manager Page 8 of 8

View Full Filing

View this SC 13G filing on SEC EDGAR